Loading…

Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia

Departments of 1 Neurosurgery, 2 Cell Biology and Physiology, and 3 Anatomy and Neurobiology, Washington University School of Medicine, and 4 St. Louis Children's Hospital, St. Louis, Missouri; 5 Departments of Anesthesiology, Pharmacology, Surgical Critical Care and Internal Medicine, and Neur...

Full description

Saved in:
Bibliographic Details
Published in:American journal of physiology. Heart and circulatory physiology 2005-08, Vol.289 (2), p.H558-H568
Main Authors: Gidday, Jeffrey M, Gasche, Yvan G, Copin, Jean-C, Shah, Aarti R, Perez, Ronald S, Shapiro, Steven D, Chan, Pak H, Park, T. S
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Departments of 1 Neurosurgery, 2 Cell Biology and Physiology, and 3 Anatomy and Neurobiology, Washington University School of Medicine, and 4 St. Louis Children's Hospital, St. Louis, Missouri; 5 Departments of Anesthesiology, Pharmacology, Surgical Critical Care and Internal Medicine, and Neuroscience, Geneva University, Geneva, Switzerland; 6 Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; and 7 Department of Neurosurgery and Department of Neurology and Neurological Sciences and Program in Neuroscience, Stanford University School of Medicine, Stanford, California Submitted 16 December 2004 ; accepted in final form 4 March 2005 Results of recent studies reveal vascular and neuroprotective effects of matrix metalloproteinase-9 (MMP-9) inhibition and MMP-9 gene deletion in experimental stroke. However, the cellular source of MMP-9 produced in the ischemic brain and the mechanistic basis of MMP-9-mediated brain injury require elucidation. In the present study, we used MMP-9 –/– mice and chimeric knockouts lacking either MMP-9 in leukocytes or in resident brain cells to test the hypothesis that MMP-9 released from leukocytes recruited to the brain during postischemic reperfusion contributes to this injury phenotype. We also tested the hypothesis that MMP-9 promotes leukocyte recruitment to the ischemic brain and thus is proinflammatory. The extent of blood-brain barrier (BBB) breakdown, the neurological deficit, and the volume of infarction resulting from transient focal stroke were abrogated to a similar extent in MMP-9 –/– mice and in chimeras lacking leukocytic MMP-9 but not in chimeras with MMP-9-containing leukocytes. Zymography and Western blot analysis from these chimeras confirmed that the elevated MMP-9 expression in the brain at 24 h of reperfusion is derived largely from leukocytes. MMP-9 –/– mice exhibited a reduction in leukocyte-endothelial adherence and a reduction in the number of neutrophils plugging capillaries and infiltrating the ischemic brain during reperfusion; microvessel immunopositivity for collagen IV was also preserved in these animals. These latter results document proinflammatory actions of MMP-9 in the ischemic brain. Overall, our findings implicate leukocytes, most likely neutrophils, as a key cellular source of MMP-9, which, in turn, promotes leukocyte recruitment, causes BBB breakdown secondary to microvascular basal lamina proteolysis, and ultimately contr
ISSN:0363-6135
1522-1539
DOI:10.1152/ajpheart.01275.2004